Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Detection and Prevention|January 1, 1988
Phase I study in malignancy of LS 2616, a new immunomodulator: methodological considerationsB I NilssonLeukemia & Lymphoma|November 1, 1993
Treatment of minimal residual disease in myeloid leukemia--the immunotherapeutic options with emphasis on LinomideJ M Rowe, B I Nilsson, B SimonssonJournal of Internal Medicine|February 1, 1995
Leucocyte doubling time is a useful predictor of progression-free survival in chronic lymphocytic leukaemiaU Axdorph, B I Nilsson, B R Nilsson, et al.Acta Physiologica Scandinavica|May 1, 1990
Relationship between interdigestive gallbladder emptying, plasma motilin and migrating motor complex in manB I Nilsson, T Svenberg, T Tollström, et al.Cancer Investigation|January 1, 1997
The first clinical pilot study of roquinimex (Linomide) in cancer patients with special focus on immunological effectsJ C Bergh, T H Tötterman, B C Termander, et al.Bone Marrow Transplantation|June 13, 2000
Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantationB Simonsson, T Tötterman, P Hokland, et al.Bone Marrow Transplantation|December 1, 1999
Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimexJ M Rowe, A P Rapoport, D H Ryan, et al.Pageof 1